期刊缩写:
DIABETES THER
影响因子:
3.8
ISSN:
print: 1869-6953
on-line: 1869-6961
研究领域:
Medicine-Endocrinology, Diabetes and Metabolism
创刊年份:
2010年
h-index:
25
自引率:
7.90%
Gold OA文章占比:
99.65%
原创研究文献占比:
82.98%
SCI收录类型:
Science Citation Index Expanded (SCIE) || Scopus (CiteScore) || Directory of Open Access Journals (DOAJ)
期刊介绍英文:
Diabetes Therapy is an international, peer reviewed, rapid-publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions (including devices) across all areas of diabetes. Studies relating to diagnostics and diagnosis, pharmacoeconomics, public health, epidemiology, quality of life, and patient care, management, and education are also encouraged. The journal is of interest to a broad audience of healthcare professionals and publishes original research, reviews, communications and letters. The journal is read by a global audience and receives submissions from all over the world. Diabetes Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research.
CiteScore:
CiteScoreSJRSNIPCiteScore排名
6.90.9380.999
学科
排名
百分位
大类:Medicine
小类:Internal Medicine
35 / 167
79%
大类:Medicine
小类:Endocrinology, Diabetes and Metabolism
68 / 244
72%
发文信息
中科院SCI期刊分区
大类 小类 TOP期刊 综述期刊
3区 医学
4区 内分泌学与代谢 ENDOCRINOLOGY & METABOLISM
WOS期刊分区
历年影响因子
2017年2.4190
2018年2.3680
2019年2.2240
2020年2.8270
2021年2.9450
2022年3.8000
历年发表
2012年16
2013年34
2014年43
2015年57
2016年73
2017年131
2018年195
2019年194
2020年235
2021年207
2022年130
投稿信息
出版周期:
12 issues per year
出版语言:
English
出版国家(地区):
ENGLAND
初审时长:
5 days
审稿时长:
6 weeks
出版商:
Springer Healthcare
编辑部地址:
TIERGARTENSTRASSE 17, HEIDELBERG, GERMANY, D-69121

Diabetes Therapy - 最新文献

The Long-Term Cost-Effectiveness of Tirzepatide 5 mg versus Dulaglutide 0.75 mg for the Treatment of People with Type 2 Diabetes in Japan.

Pub Date : 2024-12-21 DOI: 10.1007/s13300-024-01675-7 Toshihiko Aranishi, Ataru Igarashi, Kazuo Hara, Beatrice Osumili, Zhihong Cai, Aska Mizogaki, Manaka Sato, Masakazu Takeuchi, Alice Minghetti, Barnaby Hunt, Takashi Kadowaki

A Bioequivalence Study of Two Formulations of Oral Semaglutide in Healthy Participants.

Pub Date : 2024-12-21 DOI: 10.1007/s13300-024-01674-8 Mette Søndergaard Nielsen, Lise Brøndsted, Martin Kankam, Gaetano Morelli, David Nguyen, Trine Vang Skjøth, Usha Rani Patted, Marloes van Hout

The Impact of Age and Sex on Fasting Plasma Glucose and Glycated Haemoglobin (HbA1c) in the Non-diabetes Population.

Pub Date : 2024-12-20 DOI: 10.1007/s13300-024-01680-w Mike Stedman, Adrian H Heald, David Holland, Ian Halsall, Lewis Green, Pensee Wu, Kashyap Patel, Jonathan Scargill, Martin Gibson, Fahmy W F Hanna, Anthony A Fryer
查看全部
免责声明:
本页显示期刊或杂志信息,仅供参考学习,不是任何期刊杂志官网,不涉及出版事务,特此申明。如需出版一切事务需要用户自己向出版商联系核实。若本页展示内容有任何问题,请联系我们,邮箱:info@booksci.cn,我们会认真核实处理。
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信